应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06606 诺辉健康
停牌 07-18 09:20:42
14.140
+0.000
0.00%
最高
14.140
最低
14.140
成交量
0.00
今开
14.140
昨收
14.140
日振幅
0.00%
总市值
64.73亿
流通市值
64.73亿
总股本
4.58亿
成交额
0.00
换手率
0.00%
流通股本
4.58亿
市净率
1.99
ROE
4.36%
每股收益
-0.20
52周最高
14.140
52周最低
14.140
市盈率
-69.10
股息
0.00
股息收益率
0.00
ROA
-2.47%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
诺辉健康申请共同临时清盘人 股份暂停交易至另行通知
财中社 · 07-06
诺辉健康申请共同临时清盘人 股份暂停交易至另行通知
国内知名精准医疗上市企业财务造假,股价暴跌90%!
MedWorld器械世界 · 07-04
国内知名精准医疗上市企业财务造假,股价暴跌90%!
IVD上市企业,停牌15个月,准备清盘了!
IVD资讯 · 07-04
IVD上市企业,停牌15个月,准备清盘了!
停牌15个月!中国IVD上市大企股价暴跌90%!
医疗器械创新网 · 07-01
停牌15个月!中国IVD上市大企股价暴跌90%!
诺辉健康遭遇基金公司“集体看空”
环球网 · 06-30
诺辉健康遭遇基金公司“集体看空”
停牌15个月,诺辉健康的股东们大概率血本无归!
医业观察 · 06-29
停牌15个月,诺辉健康的股东们大概率血本无归!
诺辉健康遭遇基金公司“集体看空”
环球网 · 06-27
诺辉健康遭遇基金公司“集体看空”
长城基金再下调诺辉健康估值至1.20港元
DoNews · 06-25
长城基金再下调诺辉健康估值至1.20港元
最高“猛砍”90%!
中国基金报 · 06-25
最高“猛砍”90%!
港股异动 | 制药板块持续走高,中国生物制药涨近14%,绿叶制药涨近5%
老虎资讯综合 · 06-12
港股异动 | 制药板块持续走高,中国生物制药涨近14%,绿叶制药涨近5%
港股异动 | 生物医药板块多日走强,映恩生物再涨14%,三生制药涨超10%
老虎资讯综合 · 06-10
港股异动 | 生物医药板块多日走强,映恩生物再涨14%,三生制药涨超10%
港股异动 | 生物医药板块普涨,中国抗体大涨超12%,诺诚健华涨超9%
老虎资讯综合 · 06-09
港股异动 | 生物医药板块普涨,中国抗体大涨超12%,诺诚健华涨超9%
港股异动 | 生物医药板块全线反弹,百济神州涨超4%,康方生物涨超3%
老虎资讯综合 · 05-13
港股异动 | 生物医药板块全线反弹,百济神州涨超4%,康方生物涨超3%
港股异动 | 生物医药股持续回调,特朗普拟将药价立即降低30%-80%
老虎资讯综合 · 05-12
港股异动 | 生物医药股持续回调,特朗普拟将药价立即降低30%-80%
港股异动 | 生物医药板块持续高开,康方生物涨5%,本周已累涨近30%
老虎资讯综合 · 04-25
港股异动 | 生物医药板块持续高开,康方生物涨5%,本周已累涨近30%
Invesco Advisers, Inc.减持诺辉健康152.2万股 每股作价2港元
智通财经 · 04-24
Invesco Advisers, Inc.减持诺辉健康152.2万股 每股作价2港元
无余力有效履职,诺辉又2名董事辞职!
医业观察 · 04-15
无余力有效履职,诺辉又2名董事辞职!
诺辉健康(06606):刘毅基及吴永蒨辞任独立非执行董事
智通财经 · 04-14
诺辉健康(06606):刘毅基及吴永蒨辞任独立非执行董事
幽门螺杆菌:迎新药,市场格局将变?
市场资讯 · 04-12
幽门螺杆菌:迎新药,市场格局将变?
诺辉健康委任王洋为独立非执行董事
新浪港股 · 03-10
诺辉健康委任王洋为独立非执行董事
加载更多
公司概况
公司名称:
诺辉健康
所属市场:
SEHK
上市日期:
2021-02-18
主营业务:
New Horizon Health Ltd是一家主要从事结直肠癌、胃癌及宫颈癌筛查产品的研发、临床开发、测试营运及商业化业务的中国投资控股公司。该公司通过其自有网络、合同销售组织(CSO)以及由医疗诊所营运的网上销售或电子平台向客户销售常卫清、噗噗管及其他产品。该公司的幽幽管(一种基于粪便的自检胃癌筛查测试)和宫证清(一种非侵入性尿液宫颈癌家用筛查测试)产品处于开发阶段。
发行价格:
26.660
{"stockData":{"symbol":"06606","market":"HK","secType":"STK","nameCN":"诺辉健康","latestPrice":14.14,"timestamp":1752801642749,"preClose":14.14,"halted":3,"volume":0,"delay":0,"floatShares":457813108,"shares":457813108,"eps":-0.20462251847058824,"marketStatus":"停牌","change":0,"latestTime":"07-18 09:20:42","open":14.14,"high":14.14,"low":14.14,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.2634181132470588,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753061400000},"marketStatusCode":0,"adr":0,"listingDate":1613577600000,"exchange":"SEHK","adjPreClose":14.14,"openAndCloseTimeList":[[1752802200000,1752811200000],[1752814800000,1752825600000]],"volumeRatio":2.9992364356864876,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06606","defaultTab":"news","newsList":[{"id":"2549322399","title":"诺辉健康申请共同临时清盘人 股份暂停交易至另行通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2549322399","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549322399?lang=zh_cn&edition=full","pubTime":"2025-07-06 17:09","pubTimestamp":1751792997,"startTime":"0","endTime":"0","summary":"7月4日,诺辉健康(06606)发布公告,宣布公司已于2025年7月3日向开曼群岛大法院提交了共同临时清盘人的申请,并等待法院指派法官审理该案。公司表示,申请共同临时清盘人符合股东及债权人的最佳利益,并希望通过该申请来调查公司的事务、继续经营业务及制定可行的重组计划。公告中提到,公司的股份自2024年3月28日起已在联交所暂停买卖,并将继续暂停,直至另行通知。公司还强调,将在共同临时清盘人申请及呈请立案后,适时发布进一步公告,以更新股东有关清盘进展的信息。此外,公告中提到的复牌进展更新显示,尚未完成的财务业绩以及审计问题仍在处理之中,管理层的诚信和内部控制程序也需进一步验证。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250706171108979bc3dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250706171108979bc3dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06606","BK1574","BK1219"],"gpt_icon":0},{"id":"2549316048","title":"国内知名精准医疗上市企业财务造假,股价暴跌90%!","url":"https://stock-news.laohu8.com/highlight/detail?id=2549316048","media":"MedWorld器械世界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549316048?lang=zh_cn&edition=full","pubTime":"2025-07-05 07:30","pubTimestamp":1751671829,"startTime":"0","endTime":"0","summary":"财务造假风波后,诺辉健康创始人彻底出局!诺辉健康这家昔日的精准医疗独角兽企业,已经整整停牌15个月了,距离18个月的红线已经触手可及。鉴于CapitalWatch只是一个私营的机构,这次对于诺辉健康的造假指控,并没有引发实质性的后果。德勤公开直接质疑了诺辉健康若干营销活动的商业实质和商业合理性,并拒绝在财报上签字,坚持认为有必要进行独立调查。停牌前股价为14.14港元,多家基金公司将其股价估值调低至1.2港元,降幅超过90%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250705073423a72f8a0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250705073423a72f8a0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06606","BK1219"],"gpt_icon":0},{"id":"2548939197","title":"IVD上市企业,停牌15个月,准备清盘了!","url":"https://stock-news.laohu8.com/highlight/detail?id=2548939197","media":"IVD资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548939197?lang=zh_cn&edition=full","pubTime":"2025-07-04 22:04","pubTimestamp":1751637868,"startTime":"0","endTime":"0","summary":"来源:IVD资讯综合诺辉健康公告诺辉健康于2025年7月3日向开曼群岛大法院提交了有关委任共同临时清盘人的申请及清盘呈请。本公司目前正在等待大法院指派法官审理此案,随后方向大法院立案共同临时清盘人申请及呈请。本公司将在可行的情况下尽快发布进一步公告,以向股东更新有关清盘呈请及共同临时清盘人申请的最新进展。被称为“癌症早筛第一股”的诺辉健康,自2024年3月28日开始停牌,至今已经停牌了15个月之久。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704220625a72f0666&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704220625a72f0666&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06606","BK1574","BK1219"],"gpt_icon":0},{"id":"2548715390","title":"停牌15个月!中国IVD上市大企股价暴跌90%!","url":"https://stock-news.laohu8.com/highlight/detail?id=2548715390","media":"医疗器械创新网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548715390?lang=zh_cn&edition=full","pubTime":"2025-07-01 16:10","pubTimestamp":1751357457,"startTime":"0","endTime":"0","summary":"被称为“癌症早筛第一股”的诺辉健康,自2024年3月28日开始停牌,至今已经停牌了15个月之久。根据港交所的规定,个股停牌时间超过18个月,就有被强制退市的风险。诺辉健康这家昔日的精准医疗独角兽企业,已经整整停牌15个月了,距离18个月的红线已经触手可及。2023年8月15日,做空机构CapitalWatch率先向诺辉健康发难。停牌前股价为14.14港元,多家基金公司将其股价估值调低至1.2港元,降幅超过90%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701161446a727f014&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701161446a727f014&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1219","06606","BK1574"],"gpt_icon":0},{"id":"2547054678","title":"诺辉健康遭遇基金公司“集体看空”","url":"https://stock-news.laohu8.com/highlight/detail?id=2547054678","media":"环球网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547054678?lang=zh_cn&edition=full","pubTime":"2025-06-30 14:38","pubTimestamp":1751265480,"startTime":"0","endTime":"0","summary":"近期,港股上市公司诺辉健康的股价估值遭遇基金公司“集体看空”。基金公司对诺辉健康的普遍悲观态度,反映出市场对其潜在风险的高度警惕。除了诺辉健康,近期A股市场的ST紫天也遭遇基金公司估值下调。业内人士分析指出,基金公司对诺辉健康等风险标的“严厉”估值调整,不仅与其停牌期间暴露的财务疑虑、经营不确定性有关,也折射出公募基金行业在改革深化背景下,风控标准日益趋严,对上市公司质地要求更高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506301444199530e67a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506301444199530e67a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06606","BK1219","BK1574"],"gpt_icon":0},{"id":"2547889200","title":"停牌15个月,诺辉健康的股东们大概率血本无归!","url":"https://stock-news.laohu8.com/highlight/detail?id=2547889200","media":"医业观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547889200?lang=zh_cn&edition=full","pubTime":"2025-06-29 14:28","pubTimestamp":1751178508,"startTime":"0","endTime":"0","summary":"2025年,当数量不菲的港股医药股开始不断创下历史新高的时候,诺辉健康的股东们却越来越揪心。根据港交所的规定,个股停牌时间超过18个月,就有被强制退市的风险。2023年8月15日,做空机构Capital Watch率先向诺辉健康发难。鉴于Capital Watch只是一个私营的机构,这次对于诺辉健康的造假指控,并没有引发实质性的后果。直到2024年3月27日,诺辉健康的审计机构德勤公开跳反。随后,诺辉健康紧急停牌,并一直停牌到现在。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250629143256a723a20a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250629143256a723a20a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06606","BK1574","BK1219"],"gpt_icon":0},{"id":"2546767886","title":"诺辉健康遭遇基金公司“集体看空”","url":"https://stock-news.laohu8.com/highlight/detail?id=2546767886","media":"环球网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546767886?lang=zh_cn&edition=full","pubTime":"2025-06-27 11:16","pubTimestamp":1750994192,"startTime":"0","endTime":"0","summary":"近期,港股上市公司诺辉健康的股价估值遭遇基金公司“集体看空”。基金公司对诺辉健康的普遍悲观态度,反映出市场对其潜在风险的高度警惕。除了诺辉健康,近期A股市场的ST紫天也遭遇基金公司估值下调。业内人士分析指出,基金公司对诺辉健康等风险标的“严厉”估值调整,不仅与其停牌期间暴露的财务疑虑、经营不确定性有关,也折射出公募基金行业在改革深化背景下,风控标准日益趋严,对上市公司质地要求更高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506271117169790c206&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506271117169790c206&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06606","BK1219","BK1574"],"gpt_icon":0},{"id":"2546101722","title":"长城基金再下调诺辉健康估值至1.20港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546101722","media":"DoNews","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546101722?lang=zh_cn&edition=full","pubTime":"2025-06-25 20:05","pubTimestamp":1750853103,"startTime":"0","endTime":"0","summary":"6月25日,长城基金公告将诺辉健康估值由停牌前价格大幅下调91.51%,至1.20港元/股。这是继2024年7月调整至7.48港元/股后的再度下调。业内人士指出,多家基金公司相继调低估值,反映出对诺辉健康复牌前景的悲观预期。曾被誉为‘癌症早筛第一股’的诺辉健康如今估值近乎归零,也揭示了部分生物科技公司在高增长叙事背后的合规风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625200805978e6801&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625200805978e6801&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06606","BK1219","BK1574"],"gpt_icon":0},{"id":"2546212137","title":"最高“猛砍”90%!","url":"https://stock-news.laohu8.com/highlight/detail?id=2546212137","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546212137?lang=zh_cn&edition=full","pubTime":"2025-06-25 19:14","pubTimestamp":1750850040,"startTime":"0","endTime":"0","summary":"最高“猛砍”90%!6月25日,长城基金公告称,经与基金托管人协商一致,自2025年6月24日起,对旗下证券投资基金持有的停牌股票“诺辉健康”按照1.20港元/股进行估值。对此,诺辉健康予以否认。2024年9月,德勤宣布辞去诺辉健康审计机构职务。同年12月,诺辉健康创始人朱叶青辞去董事会主席及CEO职务,2025年2月,股东特别大会以79.89%的支持率罢免朱叶青的执行董事职务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625192537952b158a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625192537952b158a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06606","BK1219"],"gpt_icon":0},{"id":"1117630944","title":"港股异动 | 制药板块持续走高,中国生物制药涨近14%,绿叶制药涨近5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1117630944","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117630944?lang=zh_cn&edition=full","pubTime":"2025-06-12 09:50","pubTimestamp":1749693050,"startTime":"0","endTime":"0","summary":"本周四(6月12日)港股早盘,制药板块持续走高,截至发稿 $中国生物制药(01177)$ 涨近14%, $绿叶制药(02186)$ 涨近5%:","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"港股异动 | 制药板块持续走高,中国生物制药涨近14%,绿叶制药涨近5%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570","06618","06622","03759","03347","01643","02269","02359","01666","06996","06127","03737","01801","01177","02186","00241","06606","02273","03613"],"gpt_icon":0},{"id":"1185274559","title":"港股异动 | 生物医药板块多日走强,映恩生物再涨14%,三生制药涨超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1185274559","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185274559?lang=zh_cn&edition=full","pubTime":"2025-06-10 10:53","pubTimestamp":1749524029,"startTime":"0","endTime":"0","summary":"本周二港股早盘,生物医药板块持续走强, $映恩生物-B$ 再涨14%,两日累涨近30%, $三生制药$ 涨超10%, $康方生物$ 涨近5%:消息面上,生物医药板块正经历“创新成果兑现+全球化突破”的双重红利期。华鑫证券指出,国内创新药进入“研发投入-销售放量-回报反哺”的正循环,根据医药魔方数据,2025年Q1中国医药交易金额同比激增222%,三生制药、石药集团等Pharma类企业凭借稳定现金流支撑管线升级。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185","06160","03759","02359","02696","06622","06606","06618","01530","06996","01801","03347","02269","09606","09995","00241"],"gpt_icon":0},{"id":"1123353939","title":"港股异动 | 生物医药板块普涨,中国抗体大涨超12%,诺诚健华涨超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1123353939","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123353939?lang=zh_cn&edition=full","pubTime":"2025-06-09 10:05","pubTimestamp":1749434754,"startTime":"0","endTime":"0","summary":"本周一(6月9日)港股盘初,生物医药板块普涨,截至发稿 $中国抗体-B(03681)$ 大涨超12%, $诺诚健华(09969)$ 涨超9%:东吴证券发布研报指出,中国创新药闪耀ASCO会议,突破多个实体瘤治疗瓶颈。2025ASCO会议共有来自中国的73项口头报告,数量创下历史新高。184项ADC管线相关研究入选,其中89项来自中国,约占总体的48.4%。中国企业发布双抗研究约34项,占整体双抗研究的比例约49%。","market":"hk","thumbnail":"https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 生物医药板块普涨,中国抗体大涨超12%,诺诚健华涨超9%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06606","02269","03613","01666","02273","02359","03737","03759","06618","06996","01801","03347","01643","00570","00241","06127","06622"],"gpt_icon":0},{"id":"1152060969","title":"港股异动 | 生物医药板块全线反弹,百济神州涨超4%,康方生物涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152060969","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152060969?lang=zh_cn&edition=full","pubTime":"2025-05-13 09:29","pubTimestamp":1747099776,"startTime":"0","endTime":"0","summary":"本周二(5月13日)港股盘初,生物医药板块全线反弹,截至发稿 $百济神州(06160)$ 涨超4%, $康方生物(09926)$ 涨超3%:","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127","603259","03759","00241","06618","02359","02269","06622","WX","03347","01801","06996","06606"],"gpt_icon":0},{"id":"1181990888","title":"港股异动 | 生物医药股持续回调,特朗普拟将药价立即降低30%-80%","url":"https://stock-news.laohu8.com/highlight/detail?id=1181990888","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181990888?lang=zh_cn&edition=full","pubTime":"2025-05-12 10:11","pubTimestamp":1747015870,"startTime":"0","endTime":"0","summary":"本周一(5月12日)港股盘初,生物医药股大幅回调,截至发稿 $歌礼制药-B(01672)$ 跌超10%, $康方生物(09926)$ 、 $再鼎医药(09688)$ 均跌超6%:消息面上,美国总统特朗普称,将在白宫签署行政命令。处方药和药品价格几乎将立即降低30%至80%,美国将以全球最低价格国家的价格购买药品。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127","03759","00241","03347","02696","02359","06606","06622","06996","603259","06160","06618","09995","02269","01801","WX","06185"],"gpt_icon":0},{"id":"1166357920","title":"港股异动 | 生物医药板块持续高开,康方生物涨5%,本周已累涨近30%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166357920","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166357920?lang=zh_cn&edition=full","pubTime":"2025-04-25 09:27","pubTimestamp":1745544452,"startTime":"0","endTime":"0","summary":"本周五(4月25日)港股盘初,生物医药板块持续高开, $康方生物(09926)$ 涨5%,本周已累涨近30%, $云顶新耀-B(01952)$ 涨近5%:","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622","06996","03759","06127","00241","01801","06160","02359","06185","06606","02696","02269","09995","03347","06618"],"gpt_icon":0},{"id":"2529600084","title":"Invesco Advisers, Inc.减持诺辉健康152.2万股 每股作价2港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529600084","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529600084?lang=zh_cn&edition=full","pubTime":"2025-04-24 18:55","pubTimestamp":1745492159,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,4月17日,Invesco Advisers, Inc.减持诺辉健康(06606)152.2万股,每股作价2港元,总金额为304.4万港元。减持后最新持股数目约为3039.79万股,最新持股比例为6.77%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042419221597437e22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042419221597437e22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06606","BK1574","BK1219"],"gpt_icon":0},{"id":"2527467336","title":"无余力有效履职,诺辉又2名董事辞职!","url":"https://stock-news.laohu8.com/highlight/detail?id=2527467336","media":"医业观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527467336?lang=zh_cn&edition=full","pubTime":"2025-04-15 13:10","pubTimestamp":1744693802,"startTime":"0","endTime":"0","summary":"2025年04月14日,诺辉健康发布独立非执行董事及独立特别委员会主席,同时另一位独立非执行董事及独立特别委员会成员辞任的公告。刘先生及吴女士均已确认:彼等与董事会并无意见分歧;除截至彼等辞任前应计未结算的董事酬金外,彼等并无向本公司提出申索或诉讼权利;此前的2025年01月06日,诺辉健康发布独立非执行董事辞任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415174153a45982fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415174153a45982fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06606","BK1219","BK1574"],"gpt_icon":0},{"id":"2527169027","title":"诺辉健康(06606):刘毅基及吴永蒨辞任独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2527169027","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527169027?lang=zh_cn&edition=full","pubTime":"2025-04-14 21:21","pubTimestamp":1744636911,"startTime":"0","endTime":"0","summary":"智通财经APP讯,诺辉健康(06606)发布公告,刘毅基先生已提出辞任独立非执行董事及公司独立特别委员会主席,自2025年4月14日起生效,原因为彼相信已再无余力有效地全面履行其作为独立非执行董事及独立特别委员会主席的职责,以及妥善保障公司及其少数股东的利益;及彼希望投放更多时间于其他工作。吴永蒨女士已提出辞任独立非执行董事及独立特别委员会成员,自2025年4月14日起生效,原因为彼相信已再无余力有效地全面履行其作为独立非执行董事及独立特别委员会成员的职责,以及妥善保障公司及其少数股东的利益;及彼希望投放更多时间于其他工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1278447.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1219","06606"],"gpt_icon":0},{"id":"2527396169","title":"幽门螺杆菌:迎新药,市场格局将变?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527396169","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527396169?lang=zh_cn&edition=full","pubTime":"2025-04-12 13:33","pubTimestamp":1744435980,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 幽门螺杆菌是消化系统相当常见的致病元凶,根据流行病学的研究,全球有一半以上的人感染。我国形势同样严峻,家庭Hp感染率超七成,幽门螺杆菌根除治疗的必要性愈发凸显出来。 这折射出资本市场对幽门螺杆菌板块的高度关注。由于幽门螺杆菌相关用药只是消化系统药物的一部分,业绩情况并没有单独披露。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2025-04-12/doc-ineszrrp5891117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK4570","BK1219","06606","PPI"],"gpt_icon":0},{"id":"2518237236","title":"诺辉健康委任王洋为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2518237236","media":"新浪港股","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518237236?lang=zh_cn&edition=full","pubTime":"2025-03-10 08:17","pubTimestamp":1741565820,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 诺辉健康(06606)公布,王洋博士已获委任为独立非执行董事及董事会审核委员会成员,自2025年3月10日起生效。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-03-10/doc-inepcncv6695759.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1219","BK1574","06606"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0284},{"period":"1month","weight":0.047},{"period":"3month","weight":0.1603},{"period":"6month","weight":0.2676},{"period":"1year","weight":0.3964},{"period":"ytd","weight":0.2376}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"New Horizon Health Ltd是一家主要从事结直肠癌、胃癌及宫颈癌筛查产品的研发、临床开发、测试营运及商业化业务的中国投资控股公司。该公司通过其自有网络、合同销售组织(CSO)以及由医疗诊所营运的网上销售或电子平台向客户销售常卫清、噗噗管及其他产品。该公司的幽幽管(一种基于粪便的自检胃癌筛查测试)和宫证清(一种非侵入性尿液宫颈癌家用筛查测试)产品处于开发阶段。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.163099},{"month":2,"riseRate":1,"avgChangeRate":0.189164},{"month":3,"riseRate":0,"avgChangeRate":-0.182229},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.012258},{"month":5,"riseRate":0.666667,"avgChangeRate":0.037768},{"month":6,"riseRate":0.666667,"avgChangeRate":0.132759},{"month":7,"riseRate":0,"avgChangeRate":-0.033552},{"month":8,"riseRate":0,"avgChangeRate":-0.272889},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.160802},{"month":10,"riseRate":0.666667,"avgChangeRate":0.015313},{"month":11,"riseRate":1,"avgChangeRate":0.165661},{"month":12,"riseRate":0,"avgChangeRate":-0.147241}],"exchange":"SEHK","name":"诺辉健康","nameEN":"NH HEALTH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺辉健康(06606)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺辉健康(06606)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺辉健康,06606,诺辉健康股票,诺辉健康股票老虎,诺辉健康股票老虎国际,诺辉健康行情,诺辉健康股票行情,诺辉健康股价,诺辉健康股市,诺辉健康股票价格,诺辉健康股票交易,诺辉健康股票购买,诺辉健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺辉健康(06606)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺辉健康(06606)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}